EUVIMEDEUVIMED entdecken
Crossref

Mechanistic insights into HNRNPA2B1: A comprehensive pan-cancer analysis and functional characterization in lung cancer

Xinjie Kuang, Linghao Wu, Yufan Deng, Hongmei Huang, Yonghui Yu, Jiachun Lu, Fuman Qiu

Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 2025

DOI: 10.1016/j.bbadis.2025.167669 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2025. Verfasst von Xinjie Kuang und 6 weiteren Autor:innen. Beteiligte Einrichtung: The Key Laboratory of Advanced Interdisciplinary Studies, Institute for Chemical Carcinogenesis, School of Public Health, Guangzhou Medical Universit…. Hauptthemen laut MEDLINE: Lung Neoplasms, Heterogeneous-Nuclear Ribonucleoprotein Group A-B. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Heterogeneous nuclear ribonucleoprotein A2B1 (HNRNPA2B1), a member of the A/B subfamily of hnRNPs, plays a critical role in tumorigenesis, yet its expression patterns, molecular mechanisms, and prognostic significance remain inadequately characterized. In this study, we performed a comprehensive pan-cancer analysis utilizing multiple public databases, revealing that HNRNPA2B1 is consistently overexpressed in most tumor types and correlates with poor prognosis across several malignancies. Pathway enrichment analysis highlighted its involvement in RNA alternative splicing, transport, and stability, processes that contribute to tumor progression. Epigenetic analyses identified gene amplification and alternative splicing as potential mechanisms driving HNRNPA2B1 overexpression. Furthermore, elevated HNRNPA2B1 levels conferred resistance to multiple chemotherapeutics, including Dasatinib. Functional studies demonstrated that HNRNPA2B1 enhances lung cancer cell proliferation and migration by upregulating TARDBP and cell cycle-related genes, with m6A modification serving as a critical regulatory mechanism. Collectively, these findings establish HNRNPA2B1 as an oncogenic factor across multiple cancer types, underscoring its value as a prognostic marker and a promising therapeutic target, particularly in lung cancer, offering new insights for targeted therapeutic strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsHeterogeneous-Nuclear Ribonucleoprotein Group A-BHumansGene Expression Regulation, NeoplasticCell ProliferationAlternative SplicingPrognosisBiomarkers, TumorCell Line, TumorCell MovementEpigenesis, Genetic

Stichwörter der Autor:innen

Cell cycleHNRNPA2B1Pan-cancerTARDBPm6A modification

Substanzen

Heterogeneous-Nuclear Ribonucleoprotein Group A-BBiomarkers, Tumor

Autor:innen und Institutionen

  • The Key Laboratory of Advanced Interdisciplinary Studies, Institute for Chemical Carcinogenesis, School of Public Health, Guangzhou Medical University, 1 Xinzao Road, Panyu District, Guangzhou 511436, PR China.
  • The Key Laboratory of Advanced Interdisciplinary Studies, Institute for Chemical Carcinogenesis, School of Public Health, Guangzhou Medical University, 1 Xinzao Road, Panyu District, Guangzhou 511436, PR China; Affiliat…
  • The Key Laboratory of Advanced Interdisciplinary Studies, Institute for Chemical Carcinogenesis, School of Public Health, Guangzhou Medical University, 1 Xinzao Road, Panyu District, Guangzhou 511436, PR China. Electron…

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Kuang, X., Wu, L., Deng, Y., Huang, H., Yu, Y., Lu, J., & Qiu, F. (2025). Mechanistic insights into HNRNPA2B1: A comprehensive pan-cancer analysis and functional characterization in lung cancer. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. https://doi.org/10.1016/j.bbadis.2025.167669

Vancouver

Kuang X, Wu L, Deng Y, Huang H, Yu Y, Lu J, et al. Mechanistic insights into HNRNPA2B1: A comprehensive pan-cancer analysis and functional characterization in lung cancer. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 2025. doi:10.1016/j.bbadis.2025.167669

BibTeX
@article{Kuang2025,
  author = {Kuang, Xinjie and Wu, Linghao and Deng, Yufan and Huang, Hongmei and Yu, Yonghui and Lu, Jiachun and Qiu, Fuman},
  title = {Mechanistic insights into HNRNPA2B1: A comprehensive pan-cancer analysis and functional characterization in lung cancer},
  journal = {Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease},
  year = {2025},
  doi = {10.1016/j.bbadis.2025.167669}
}
Kostenlos starten →